What is CEDS and the endocannabinoid system
The endocannabinoid system is a messaging system in your body (a series of chemical transmitters and receptors) that modulate just about every physiological function in your body. The endocannabinoid system:
- regulates pain and inflammation pathways – in your joints and organs
- affects how you sleep and how you feel (emotions)
- regulates your appetite and metabolism
- affects your memory and thinking (cognition)
- regulates gastro-intestinal / gut function
- regulates the protection and development of nerves in your body
For different reasons, such as lifestyle triggers or genetic factors, the ECS can be under-functioning in many people, and this results in symptoms that often take years to develop. This is now known as Clinical Endocannabinoid Deficiency Syndrome (CEDS). Symptoms of CEDS may include
Anxiety and Depression
Migraines and Headaches
Gastro-intestinal and metabolism dysfunction
Nerve vulnerability and deterioration
Pain, Inflammation and Fibromyalgia
Memory, thinking and cognition problems
Insomnia and other Sleep issues
Repetitive failed treatment
If this is you, you may be one of the 3 million Australians with CEDS, book your free consultation to speak with our CEDS specialists.
The Studies Behind It
We have teamed up with CANNect Group and Monash Clinical Research to see how patients went with our treatments.
Our patient outcome results are in!
66% of patients reduced their opioid use while significantly improving their quality of life.
Why not treat my symptoms, instead of the ECS
Many people will undergo many failed, or underperforming treatments of CEDS symptoms. CEDS is a widespread imbalance in the body, potentially resulting in a plethora of symptoms, and impacting the effectiveness of other treatments.
- supplementing ECS chemical transmitters – to get the system functioning more like normal
- doing things that boost your ECS – at home or with help
Ongoing Thanks
To a Pioneer and a Friend
We extend our sincerest thanks to Raphael Mechoulam, who needs no introduction as one of the world’s most accomplished research scientists in the area of cannabinoids and endocannabinoids. His research from 1963 enabled the first synthesis of THC as well as the research discovery of the endocannabinoids anandamide and 2-AG. Raphael continues to inspire our key research team around the world. Learn more about Raphael here.
The term CEDS is a relatively recent one. And that’s because there are so many things about the ECS that we are still discovering.